Calcium intake, vascular calcification, and vascular disease

Nutrition Reviews

Volumn 71, Issue 1, 2013, Pages 15-22

  Spence, Lisa A ^a   Weaver, Connie M ^b  

^a PURDUE UNIVERSITY   (United States)

^b Tate and Lyle Speciality Sweeteners   (United Kingdom)

Author keywords

Calcium supplements; Cardiovascular disease; Myocardial infarction; Vascular calcification

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CALCIUM INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DIET SUPPLEMENTATION; HEART INFARCTION; HUMAN; MEDLINE; META ANALYSIS (TOPIC); MORTALITY; OBSERVATIONAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC);

CALCINOSIS; CALCIUM, DIETARY; DIETARY SUPPLEMENTS; HUMANS; RISK FACTORS; VASCULAR DISEASES;

SUIDAE;

EID: 84871858669     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/nure.12002     Document Type: Article

References (82)

1. Bolland MJ, Avenell A, Baron JA, etal. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: Meta-analysis. BMJ. 2010;341:c3691.
2. Bolland MJ, Grey A, Avenell A, etal. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ. 2011;342:d2040.
3. Pentti K, Tuppurainen MT, Honkanen R, etal. Use of calcium supplements and the risk of coronary heart disease in 52-62-year-old women: the Kuopio Osteoporosis Risk Factor and Prevention Study. Maturitas. 2009;63:73-78.
4. Bolland MJ, Barber PA, Doughty RN, etal. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ. 2008;336:262-266.
5. Reid IR, Bolland M, Avenell A, etal. Cardiovascular effects of calcium supplementation. Osteoporos Int. 2011;22:1649-1658.
6. Reid IR, Schooler BA, Hannon S, etal. The acute biochemical effects of four proprietary calcium supplements. Aust N Z J Med. 1986;16:193-197.
7. Reid IR, Bolland MJ, Grey A. Does calcium supplementation increase cardiovascular risk? Clin Endocrinol (Oxf). 2010;73:689-695.
8. Wilson PW, Kauppila LI, O'Donnell CJ, etal. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation. 2001;103:1529-1534.
9. Pletcher MJ, Tice JA, Pignone M, etal. Using the coronary artery calcium scores to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med. 2004;164:1285-1292.
10. U.S. Department of Health and Human Services. Bone Health and Osteoporosis: A Report of the Surgeon General 2004. Rockville, MD, USA. 2004; Available at: http://www.surgeongeneral.gov/library/reports/bonehealth/OsteoBrochuremar05.pdf. Accessed Accessed 25 November 2012.
11. American Society for Bone and Mineral Research. Statement on Potential Cardiovascular Risks Associated with Calcium Supplements. August 12, 2010; Available at: http://www.asbmr.org/About/detail.aspx?cid=80efb4d9-d696-46c8-b83b-3e0940c9dddd. Accessed 13 September 2011.
12. Bailey RL, Gahche JJ, Lentino CV, etal. Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr. 2010;140:817-822.
13. Fulgoni VL III, Keast DR, Bailey RL, etal. Foods, fortificants, and supplements: where do Americans get their nutrients? J Nutr. 2011;141:1847-1854.
14. Bockman RS, Zapalowski C, Kiel DP, etal. The Challenges of the Single Micronutrient Study Commentary on Calcium Supplements and Cardiovascular Events. ASBMR Professional Practice Committee Report on the Safety of Calcium Supplementation. June 8, 2011; Available at: http://www.asbmr.org/About/detail.aspx?cid=3c1575bc-86cb-49bf-b397-2c748fe86581. Accessed 13 September 2011.
15. Bostick RM, Kushi LH, Wu Y, etal. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol. 1999;149:151-161.
16. Reddy VS, Good M, Howard PA, etal. Role of vitamin D in cardiovascular health. Am J Cardiol. 2010;106:798-805.
17. Denke MA, Fox MM, Schulte MC. Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men. J Nutr. 1993;123:1047-1053.
18. Reid IR, Mason B, Horne A, etal. Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial. Am J Med. 2002;112:343-347.
19. van Mierlo LA, Arends LR, Streppel MT, etal. Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. J Hum Hypertens. 2006;20:571-580.
20. Houston MC, Harper KJ. Potassium, magnesium, and calcium: their role in both the cause and treatment of hypertension. J Clin Hypertens (Greenwich). 2008;10(Suppl 2):3-11.
21. Zemel MB, Shi H, Greer B, etal. Regulation of adiposity by dietary calcium. FASEB J. 2000;14:1132-1138.
22. Onakpoya IJ, Perry R, Zhang J, etal. Efficacy of calcium supplementation for management of overweight and obesity: systematic review of randomized clinical trials. Nutr Rev. 2011;69:335-343.
23. Pittas AG, Lau J, Hu FB, etal. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92:2017-2029.
24. Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr. 2011;65:1005-1015.
25. Baron JA, Beach M, Mandel JS, etal. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med. 1999;340:101-107.
26. Lappe JM, Travers-Gustafson D, Davies KM, etal. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85:1586-1591.
27. Peterlik M, Grant WB, Cross HS. Calcium, vitamin D, and cancer. Anticancer Res. 2009;29:3687-3698.
28. LaCroix AZ, Kotchen J, Anderson G, etal. Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2009;64:559-567.
29. Iso H, Stampfer MJ, Manson JE, etal. Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke. 1999;30:1772-1779.
30. Peterlik M, Cross HS. Vitamin D and calcium insufficiency-related chronic diseases: molecular and cellular pathophysiology. Eur J Clin Nutr. 2009;63:1377-1386.
31. Guessous I, Bochud M, Bonny O, etal. Calcium, vitamin D, and cardiovascular disease. Kidney Blood Press Res. 2011;34:404-417.
32. Chung M, Balk EM, Brendel M, etal. Vitamin D and calcium: a systematic review of health outcomes. Evid Rep Technol Assess (Full Rep). 2009;183:1-420.
33. Lewis JR, Calver J, Zhu K, etal. Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of a 5-year RCT and a 4.5-year follow-up. J Bone Miner Res. 2011;26:35-41.
34. 3 and calcium for secondary prevention of low trauma fractures in elderly people (Randomised Evaluation of Calcium or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet. 2005;365:1621-1628.
35. Hsia J, Heiss G, Ren H, etal. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007;115:846-854.
36. Manson JE, Allison MA, Carr JJ, etal. Women's Health Initiative and Women's Health Initiative-Coronary Artery Calcium Study Investigators. Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative. Menopause. 2010;17:683-691.
37. Mursu J, Robien K, Harnack LJ, etal. Dietary supplements and mortality rate in older women: the Iowa Women's Health Study. Arch Intern Med. 2011;171:1625-1633.
38. Nurmi-Lüthje I, Sund R, Juntunen M, etal. Post-hip fracture use of prescribed calcium plus vitamin D or vitamin D supplements and antiosteoporotic drugs is associated with lower mortality: a nationwide study in Finland. J Bone Miner Res. 2011;26:1845-1853.
39. Soedamah-Muthu SS, Ding EL, Al-Delaimy WK, etal. Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. Am J Clin Nutr. 2011;93:158-171.
40. Aslibehyan S, Campos H, Baylin A. Biomarkers of dairy intake and the risk of heart disease. Nutr Metab Cardiovasc Dis. 2011; doi: 10.1016/j.numecd.2011.02.003.[Epub ahead of print].
41. Warensjo E, Jansson J-H, Cederholm T, etal. Biomarkers of milk fat and the risk of myocardial infarction in men and women: a prospective, matched case-control study. Am J Clin Nutr. 2010;92:194-202.
42. Goldbohm RA, Chorus AMJ, Garre FG, etal. Dairy consumption and 10-y total and cardiovascular mortality: a prospective cohort study in the Netherlands. Am J Clin Nutr. 2011;93:615-627.
43. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167:1730-1737.
44. Ginde AA, Scragg R, Schwartz RS, etal. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc. 2009;57:1595-1603.
45. Kilkkinen A, Knekt P, Aro A, etal. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol. 2009;170:1032-1039.
46. Pilz S, Tomaschitz A, Drechsler C, etal. Vitamin D deficiency and myocardial diseases. Mol Nutr Food Res. 2010;54:1103-1113.
47. Pittas AG, Chung M, Trikalinos T, etal. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010;152:307-314.
48. Geleijnse JM. Vitamin D and the prevention of hypertension and cardiovascular diseases: a review of the current evidence. Am J Hypertens. 2011;24:253-262.
49. Miller PD. Vitamin D, calcium, and cardiovascular mortality: a perspective from a plenary lecture given at the annual meeting of the American Association of Clinical Endocrinologists. Endocr Pract. 2011;19:1-30.
50. Daly RM, Ebeling PR. Is excess calcium harmful to health? Nutrients. 2010;2:505-522.
51. Wang L, Manson JE, Song Y, etal. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med. 2010;152:315-323.
52. Sabbagh Z, Vatanparast H. Is calcium supplementation a risk factor for cardiovascular diseases in older women? Nutr Rev. 2009;67:105-108.
53. Abrahamsen B. Do calcium plus vitamin D supplements increase cardiovascular risk? BMJ. 2011;342:d2080.
54. Burckhardt P. Potential negative cardiovascular effects of calcium supplements. Osteoporos Int. 2011;22:1645-1647.
55. Nordin BE, Daly RM, Horowitz J, etal. Making too much of a weak case. BMJ. 2010;341:c4997.
56. Nordin BE, Lewis JR, Daly RM, etal. The calcium scare - what would Austin Bradford Hill have thought? Osteoporos Int. 2011;22:3073-3077.
57. Lewis JR, Zhu K, Prince RL. Adverse events from calcium supplementation: relationship to errors in myocardial infarction self-reporting in randomized controlled trials of calcium supplementation. J Bone Miner Res. 2012;27:719-722.
58. Goodman WG, Goldin J, Kuizon BD, etal. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478-1483.
59. Brock GA, Raggi P, Bellasi A, etal. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int. 2007;71:438-441.
60. Russo D, Miranda I, Ruocco C, etal. The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int. 2007;72:1255-1261.
61. Elder GJ. Calcium supplementation: lessons from the general population for chronic kidney disease and back. Curr Opin Nephrol Hypertens. 2011;20:369-375.
62. West SL, Swan VJ, Jamal SA. Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population. Clin J Am Soc Nephrol. 2010;5(Suppl 1):S41-S47.
63. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002;62:245-252.
64. Qunibi W, Moustafa M, Muenz LR, etal. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am J Kidney Dis. 2008;51:952-965.
65. Bhakta M, Bruce C, Messika-Zeitoun D, etal. Oral calcium supplements do not affect the progression of aortic valve calcification or coronary artery calcification. J Am Board Fam Med. 2009;22:610-616.
66. Van Pelt N, Ruygrok P, Bolland MJ, etal. Do calcium supplements lead to an increase in coronary calcification? Heart Lung Circ. 2009;18S:S241.
67. Zhang Q-L, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health. 2008;8:117. doi:10.1186/1471-2458-8-117
68. Go AS, Chertow GM, Fan D, etal. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305.
69. LaCrois AZ, Lee JS, Wu LL, etal. Cystatin-C, renal function, and incidence of hip fracture in postmenopausal women. J Am Geriatr Soc. 2008;56:1434-1441.
70. Jamal SA, Bauer DC, Ensrud KE, etal. Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial. J Bone Miner Res. 2007;22:503-508.
71. Hsu HHT, Culley NC. Effects of dietary calcium on atherosclerosis, aortic calcification, and icterus in rabbits fed a supplemental cholesterol diet. Lipids Health Dis. 2006;5:16. doi:10.1186/1476-511x-5-16.
72. 41Ca methodology. J Clin Endocrinol Metab. 2009;94:3798-3805.
73. 41Ca. J Clin Endocrinol Metab. 2007;92:577-585.
74. Cheong JMK, Gunaratna NS, McCabe GP, etal. Bone-seeking labels as markers for bone turnover: validation of urinary excretion in rats. Osteoporos Int. 2011;22:153-157.
75. 41Ca data using compartmental modeling in post-menopausal women. Anal Bioanal Chem. 2011;399:1613-1622.
76. Wastney M, Lee WH, Jackson GS, etal. Soft tissue calcification in the Ossabaw miniature pig: experimental and kinetic modeling studies. Osteoporos Int. 2013;[in press].
77. Neeb ZP, Edwards JM, Alloosh M, etal. Metabolic syndrome and coronary artery disease in Ossabaw compared with Yucatan swine. Comp Med. 2010;60:300-315.
78. Buclin T, Jacquet AF, Burckhardt P. Absorption intestinale degluconate de calcium et de complexe osséino-minéral: évaluation par des dosages conventionnels [in French]. Schw Med Wochenschr. 1986;116:1780-1783.
79. Prince RL, Devine A, Dhaliwal SS, etal. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med. 2006;166:869-875.
80. Lappe JM, Heaney RP. Calcium supplementation: results may not be generalisable. BMJ. 2008;336:403-406. PMC2249636.
81. Hanzlik RP, Fowler SC, Fisher DH. Relative bioavailability of calcium from calcium formate, calcium citrate, and calcium carbonate. J Pharmacol Exp Ther. 2005;313:1217-1222.
82. Shah SM, Carey IM, Harris T, etal. Calcium supplementation, cardiovascular disease and mortality in older women. Pharmacoepidemiol Drug Saf. 2010;19:59-64.